跳至主要内容
临床试验/NCT00367393
NCT00367393已完成4 期

An Open-label Multicenter 12-month Long Term Study on Skin Reconstitution With Pimecrolimus Cream 1% in Adult Patients With Atopic Eczema and Corticosteroid Induced Skin Damage

Novartis1 个研究点 分布在 1 个国家目标入组 41 人开始时间: 2006年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
Novartis
入组人数
41
试验地点
1
主要终点
• Decrease of the Dermatophot (a combination of a dermatoscope and a camera) score on skin deterioration and spider veins from baseline to end of the study

研究概览

简要总结

Topical steroid use may lead to skin deterioration and spider veins. This study will examine long-term management of atopic dermatitis (AD) over 12 months with pimecrolimus cream 1% and its effect on skin reconstitution of steroid-damaged skin and disease control.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • clinically diagnosed AD
  • almost clear to mild AD (local IGA [target lesions face and cubital areas] score of 1-3)
  • clinically (i.e. to the unaided eye) evident skin atrophy due to long-term topical steroid use
  • Dermatophot Score (DPS - composed of skin atrophy and telangiectasia) of 4-6 on at least two target areas

排除标准

  • Phototherapy or systemic therapy known or suspected to have an effect on AD within 4 weeks prior to study entry
  • Topical therapy known or suspected to have an effect on AD within 7 days prior to study entry or systemic corticosteroids within 4 weeks prior to study entry
  • Clinical conditions other than AD that according to investigator can interfere with the Dermatophot evaluation

研究组 & 干预措施

1

Experimental

Pimecrolimus cream 1%

干预措施: Pimecrolimus cream 1% (Drug)

结局指标

主要结局

• Decrease of the Dermatophot (a combination of a dermatoscope and a camera) score on skin deterioration and spider veins from baseline to end of the study

时间窗: 48 weeks

次要结局

  • Skin metabolism by suction blisters.(48 weeks)
  • • Epidermal thickness by optical coherence tomography at selected investigational centers(48 weeks)
  • Skin thickness by ultrasound at selected investigational centers(48 weeks)
  • Epidermal thickness by 3mm punch biopsies (optional)(48 weeks)
  • Investigator's Global Assessment (IGA)(48 weeks)

研究者

发起方
Novartis
申办方类型
Industry

研究点 (1)

Loading locations...

相似试验